Helius Medical Technologies, Inc. Partners with the Medical University of South Carolina in Pilot Trial on Stroke
December 17, 2021 07:05 ET
|
Helius Medical Technologies, Inc.
-- PoNS ® to be used in study of cranial-nerve non-invasive neuromodulation and dynamic gait balance in stroke patients -- -- Collaboration will inform Helius’s registrational program in stroke -- ...
Helius Medical Technologies, Inc. Announces Issuance of U.S. Patent for Wireless PoNS®
December 14, 2021 07:05 ET
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., Dec. 14, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (Helius or the Company), a neurotech company focused on neurological wellness, today announced that...
Helius Medical Technologies, Inc.’s Dr. Antonella Favit-Van Pelt to Present at 4th International Brain Stimulation Conference on December 9
December 06, 2021 07:05 ET
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., Dec. 06, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced...
Helius Medical Technologies, Inc. to Participate in 1x1 Meetings at 12th Annual Craig-Hallum Alpha Select Conference on November 16, 2021
November 15, 2021 06:50 ET
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (Helius), a neurotech company focused on neurological wellness, today announced that Dane C....
Helius Medical Technologies, Inc. Announces Closing of $11.1 Million Underwritten Public Offering of Common Stock Including Full Exercise of Over-Allotment Option
November 12, 2021 16:05 ET
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., Nov. 12, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced...
Helius Medical Technologies, Inc. Reports Third Quarter 2021 Financial Results
November 10, 2021 16:05 ET
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today reported...
Helius Medical Technologies, Inc. Announces Pricing of $9.6 Million Underwritten Public Offering of Common Stock
November 10, 2021 08:30 ET
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced...
Helius Medical Technologies, Inc. Announces Proposed Underwritten Public Offering of Common Stock
November 09, 2021 16:30 ET
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced...
Helius Medical Technologies, Inc. Launches Therapeutic Experience Program; NYU Langone Health Is Initial Clinical Trial Site
November 08, 2021 07:05 ET
|
Helius Medical Technologies, Inc.
-- Multi-center, company-sponsored, open label observational interventional trial to evaluate impact of subjects’ adherence to PoNS® therapy for gait improvement in Multiple Sclerosis ---- Program to...
Helius Medical Technologies, Inc. Receives PoNS® Market Authorization in Australia
November 04, 2021 06:55 ET
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (Helius or the Company), a neurotech company focused on neurological wellness, today announced it...